Literature DB >> 28148585

Behcet's disease.

Jagdish R Nair1, Robert J Moots2.   

Abstract

Behçet's disease (BD) is a chronic relapsing and remitting vasculitis of unknown aetiology. It has the capacity to affect almost all organ systems because of its potential to involve both arteries and veins of all sizes, resulting in significant organ-threatening morbidity and mortality. Traditionally known as the 'silk road' disease, it has a worldwide occurrence. The aetiopathological mechanisms of disease development in BD remain poorly understood, but genome wide studies show human leukocyte antigen and non-human leukocyte antigen associations. Environmental influences and genetic factors may have a role in the aetiopathogenetic mechanisms that lead to development of the disease, indicating the autoimmune and auto-inflammatory nature of BD. The evidence base for treatment is limited but new knowledge is emerging and current treatment options range from symptomatic treatment, through to non-biological and biological immunosuppressive drugs, to cover the spectrum of clinical manifestations. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Behcet's disease; biological drugs; disease-modifying drugs; immunosuppression; vasculitis

Mesh:

Year:  2017        PMID: 28148585      PMCID: PMC6297594          DOI: 10.7861/clinmedicine.17-1-71

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  52 in total

1.  Behçet's disease: evaluation of a new instrument to measure clinical activity.

Authors:  B B Bhakta; P Brennan; T E James; M A Chamberlain; B A Noble; A J Silman
Journal:  Rheumatology (Oxford)       Date:  1999-08       Impact factor: 7.580

2.  Behçet's syndrome: response to infliximab after failure of etanercept.

Authors:  C Estrach; S Mpofu; R J Moots
Journal:  Rheumatology (Oxford)       Date:  2002-10       Impact factor: 7.580

3.  Segmental pulmonary artery aneurysms with peripheral venous thrombosis.

Authors:  J P HUGHES; P G STOVIN
Journal:  Br J Dis Chest       Date:  1959-01

4.  A double-blind trial of colchicine in Behçet's syndrome.

Authors:  S Yurdakul; C Mat; Y Tüzün; Y Ozyazgan; V Hamuryudan; O Uysal; M Senocak; H Yazici
Journal:  Arthritis Rheum       Date:  2001-11

5.  Aortic and arterial aneurysms in behçet disease: management with stent-grafts--initial experience.

Authors:  J H Park; J W Chung; J H Joh; S Y Song; S J Shin; K S Chung; D Y Lee; J Y Won; S J Kim
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

6.  Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.

Authors:  B Wechsler; B Bodaghi; D L Huong; C Fardeau; Z Amoura; N Cassoux; J C Piette; P LeHoang
Journal:  Ocul Immunol Inflamm       Date:  2000-12       Impact factor: 3.070

7.  Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.

Authors:  Erkan Alpsoy; Cicek Durusoy; Ertan Yilmaz; Yilmaz Ozgurel; Oya Ermis; Sahin Yazar; Erdal Basaran
Journal:  Arch Dermatol       Date:  2002-04

8.  Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.

Authors:  Ina Kötter; Reinhard Vonthein; Manfred Zierhut; Anja Katrin Eckstein; Thomas Ness; Ilhan Günaydin; Bodo Grimbacher; Sabine Blaschke; Hans Hartmut Peter; Nicole Stübiger
Journal:  Semin Arthritis Rheum       Date:  2004-04       Impact factor: 5.532

9.  Abdominal aortic aneurysm in Behçet's disease: new treatment options for an old and challenging problem.

Authors:  Samy S Nitecki; Amos Ofer; Tony Karram; Henry Schwartz; Ahuva Engel; Aaron Hoffman
Journal:  Isr Med Assoc J       Date:  2004-03       Impact factor: 0.892

10.  Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.

Authors:  Khalifa E Sharquie; Rafid A Najim; Ahmed R Abu-Raghif
Journal:  J Dermatol       Date:  2002-05       Impact factor: 4.005

View more
  18 in total

1.  Beyond Human Leukocyte Antigen Class I Antigens: Hereditary Hemochromatosis Gene Mutations in Recurrent Aphthous Oral Ulcers and Behçet Disease in the South of Tunisia.

Authors:  Sahar ElAoud; Arwa Kamoun; Nadia Mahfoudh; Aida Charfi; Mouna Snoussi; Hend Hachicha; Ameni Jerbi; Chifa Dammak; Feten Frikha; Faiza Hakim; Lilia Gaddour; Zouheir Bahloul; Hafedh Makni
Journal:  Med Princ Pract       Date:  2017-09-26       Impact factor: 1.927

Review 2.  Apremilast: A Review in Oral Ulcers of Behçet's Disease.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2020-02       Impact factor: 9.546

Review 3.  Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

Authors:  Anthony Nguyen; Shubhra Upadhyay; Muhammad Ali Javaid; Abdul Moiz Qureshi; Shahan Haseeb; Nismat Javed; Christopher Cormier; Asif Farooq; Abu Baker Sheikh
Journal:  Inflamm Intest Dis       Date:  2021-11-04

4.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

5.  Evaluation of factors for predicting risk of uveitis recurrence in Behcet's disease patients.

Authors:  Jianfei Cai; Lin Qi; Yong Chen; Jun Zou; Yan Shen; Dan Luo; Huafang Bao; Jingfen Ye; Haifen Ma; Jian-Long Guan
Journal:  Braz J Med Biol Res       Date:  2020-05-08       Impact factor: 2.590

6.  Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.

Authors:  T Novak; F Fortune; L Bergmeier; I Khan; E Hagi-Pavli
Journal:  Clin Exp Immunol       Date:  2020-07-29       Impact factor: 4.330

Review 7.  Incomplete intestinal obstruction as the possible main complaint in Behcet's disease after surgery for recurrent abdominal aortic pseudoaneurysms: a case report and literature review.

Authors:  Fang Jiang; Hui Xiang; Zhi-Yong Peng
Journal:  BMC Cardiovasc Disord       Date:  2018-12-17       Impact factor: 2.298

Review 8.  Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses.

Authors:  Dehai Xian; Jing Song; Lingyu Yang; Xia Xiong; Rui Lai; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

9.  Upper gastrointestinal hemorrhage and thoracic aortic aneurysm rupture as presenting signs of Behçet disease: A case report.

Authors:  Li-Fei Yu; Li-Wei Guo; Jiang-Ping He; Bin Yang; Chuang-Hua Chen; Jie Jin
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

Review 10.  Pulmonary artery thrombosis as the first presentation of Behçet's syndrome: a case report and review of the literature.

Authors:  Ziyad Alakkas; Waad Kazi; Mohamed Mattar; Eman Abdul Wahhab Salem; Naglaa Fawzy Seleem
Journal:  J Med Case Rep       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.